BioSpace News Archive

Bionik Laboratories Corp. will present at the 2022 Investor Summit Q4 Micro-Cap Conference.

Ainos, Inc. today announced its unaudited financial results for the third quarter ended September 30, 2022.

Syros Pharmaceuticals today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Monday, November 14, 2022 to report its third quarter 2022 financial results and provide a corporate update.

Glaukos Corporation today announced that its management is scheduled to participate in the Stephens Annual Investment Conference on Wednesday, November 16, 2022, at 2:00 p.m. CT in Nashville, TN.

NextCure, Inc today announced that clinical trial investigator Emese Zsiros, M.D., Ph.D., Associate Professor of Oncology, Chair, Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, will present initial clinical data from a Phase 1 clinical trial of NC762.

Vaccitech plc today announced an update to the interim analysis of safety and efficacy data from its HBV002 trial (NCT04778904).

Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced financial results for the third quarter ended September 30, 2022.

Hepion Pharmaceuticals, Inc. today announced that its Chief Scientific Officer, Daren Ure, PhD, will present data highlighting the poly-indication potential of its lead drug candidate, rencofilstat, at the upcoming 6th Annual Antifibrotic Drug Development Summit, taking place November 9-11, 2022, in Boston, MA.

Relay Therapeutics, Inc. is scheduled to participate in two fireside chats this month at the H.C. Wainwright 3rd Annual Precision Oncology Virtual Conference on Monday, November 14, 2022 at 10:00 a.m. ET and the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022, at 1:15 p.m. ET.

F-star Therapeutics, Inc. today announced the publication of safety and efficacy results from Phase 1 trial of FS118 in patients with advanced cancer and PD-L1 resistance in Clinical Cancer Research, a journal of the American Association for Cancer Research.